Related Experiment Video
Updated: Sep 30, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
The first step is recognizing there is a problem: a methodology for adjusting for variability in disease severity
Meagan Bechel1, Adam R Pah2,3, Stephen D Persell4,5
1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
A new metric accurately measures clinician recognition of acute respiratory distress syndrome (ARDS), accounting for patient severity and hospital standards. Physicians with specialized training showed higher ARDS recognition rates, highlighting a need for targeted interventions.
Area of Science:
- Medical innovation adoption
- Clinical decision-making
- Healthcare quality improvement
Background:
- Innovation adoption in medicine is often impeded by challenges in recognizing target conditions.
- Difficulties arise from integrating diverse patient data and heterogeneous disease presentations.
- Accurate disease recognition is crucial for implementing evidence-based practices.
Purpose of the Study:
- To develop and validate a data-driven metric for assessing clinician disease recognition.
- To evaluate the metric using acute respiratory distress syndrome (ARDS) recognition as a case study.
- To identify factors influencing physician recognition of ARDS.
Main Methods:
- A general data-driven metric was proposed to account for patient disease severity and institutional standards.
- The metric was applied to assess ventilatory management of 362 ARDS patients at an academic hospital.
- Physician recognition performance was correlated with provider characteristics and self-reported barriers.
Main Results:
- The developed metric proved robust against patient characteristics like disease severity and height.
- Physician training background was the sole significant factor associated with recognition performance.
- Pulmonary and critical care medicine (PCCM) training correlated with higher ARDS recognition (β=0.63, p<7×10⁻⁵).
Conclusions:
- A novel data-driven metric enables objective assessment of clinician disease recognition, considering patient variability and institutional factors.
- The metric identified distinct physician groups requiring tailored interventions for improved recognition.
- Physicians with lower recognition rates reported fewer perceived barriers, indicating a potential unawareness of institutional challenges.
More Related Videos
02:28Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Regression Toward the Mean
Systematic Error: Methodological and Sampling Errors
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...